Torrent Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of ₹2,452 Crore, up from ₹ Crore year on year depicting a growth of 17%. Consolidated Net Profit of ₹287 Crore, up 343% from -(₹118) Crore in the same quarter of the previous year. The Earnings per Share is ₹8.48, up 343% from -(₹3.49) in the same quarter of the previous year.
Torrent Pharmaceuticals Ltd Q4FY23 revenue grows by 17%
Related Post
- Patanjali Foods Ltd Q4FY24; 22% fall in Profits
Ruchi Soya Industries Limited is engaged primarily in the business of processing of oil-seeds and…
-
Zomato Ltd Q4 FY24 Earnings Conference Call Insights
Key highlights from Zomato Ltd (ZOMATO) Q4 FY24 Earnings Concall Quick Commerce Expansion Blinkit plans…
-
Thyrocare Technologies Ltd Q4FY24; 90% rise in Profits
Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing…